Abstract:Abstract Background CRISPR-Cas based diagnostic assays provide a portable solution which bridges the benefits of qRT-PCR and serological assays in terms of portability, specificity and ease of use. CRISPR-Cas assays are rapidly fieldable, specific and have been rigorously validated against a number of targets, including HIV and vector-borne pathogens. Recently, CRISPR-Cas12 and CRISPR-Cas13 diagnostic assays have been granted FDA approval for the detection of SARS-CoV-2. A critical step in utilizing this technology requires the design of highly-specific and efficient CRISPR RNAs (crRNAs) and isothermal primers. This process involves intensive manual curation and stringent parameters for design in order to minimize off-target detection while also preserving detection across divergent strains. As such, a single, streamlined bioinformatics platform for rapidly designing crRNAs for use with the CRISPR-Cas12 platform is needed. Here we offer PrimedSherlock, an automated, computer guided process for selecting highly-specific crRNAs and primers for targets of interest. Results Utilizing PrimedSherlock and publicly available databases, crRNAs were designed against a selection of Flavivirus genomes, including West Nile, Zika and all four serotypes of Dengue. Using outputs from PrimedSherlock in concert with both wildtype A.s Cas12a and Alt-R Cas12a Ultra nucleases, we demonstrated sensitive detection of nucleic acids of each respective arbovirus in in-vitro fluorescence assays. Moreover, primer and crRNA combinations facilitated the detection of their intended targets with minimal off-target background noise. Conclusions PrimedSherlock is a novel crRNA design tool, specific for CRISPR-Cas12 diagnostic platforms. It allows for the rapid identification of highly conserved crRNA targets from user-provided primer pairs or PrimedRPA output files. Initial testing of crRNAs against arboviruses of medical importance demonstrated a robust ability to distinguish multiple strains by exploiting polymorphisms within otherwise highly conserved genomic regions. As a freely-accessible software package, PrimedSherlock could significantly increase the efficiency of CRISPR-Cas12 diagnostics. Conceptually, the portability of detection kits could also be enhanced when coupled with isothermal amplification technologies.

Krisp: A Python package to aid in the design of CRISPR and amplification-based diagnostic assays from whole genome sequencing data

PathoGD: an integrative genomics approach for CRISPR-based target design of rapid pathogen diagnostics

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

Development and application of sensitive, specific, and rapid CRISPR‐Cas13‐based diagnosis

SHERLOCK: nucleic acid detection with CRISPR nucleases

PrimedSherlock: a tool for rapid design of highly specific CRISPR-Cas12 crRNAs

Developing, characterizing and modeling CRISPR-based point-of-use pathogen diagnostics

CRISPR-detector: fast and accurate detection, visualization, and annotation of genome-wide mutations induced by genome editing events

CRISPR-Cas Systems: Programmable Nuclease Revolutionizing the Molecular Diagnosis

CRISPR Cas system: A strategic approach in detection of nucleic acids

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

CRISPR-Cas, Argonaute proteins and the emerging landscape of amplification-free diagnostics

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics

CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens

Ultra-sensitive and High-Throughput CRISPR-p Owered COVID-19 Diagnosis

Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms

Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application

CRISPR-based nucleic acid diagnostics for pathogens